Facebook tracking pixel
Z85.46
ICD-10-CM
History of Prostate Carcinoma

Understand the history of prostate carcinoma diagnosis including clinical documentation, medical coding (ICD-10 C61), staging (TNM), Gleason score, and PSA levels. Find information on risk factors, screening, diagnostic procedures like biopsy, and treatment options for prostate cancer. This resource offers guidance for healthcare professionals on accurate and complete documentation for optimal patient care and reimbursement.

Also known as

History of Prostate Cancer
Hx of Prostate Carcinoma
hx of prostate cancer
+1 more

Diagnosis Snapshot

Key Facts
  • Definition : Prior diagnosis of prostate cancer, now treated or in remission.
  • Clinical Signs : May be asymptomatic. Possible elevated PSA, abnormal DRE, or positive biopsy history.
  • Common Settings : Primary care, urology, oncology follow-up, or survivorship clinics.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC Z85.46 Coding
Z85.4

Personal history of malignant neoplasm of prostate

History of prostate cancer.

C61

Malignant neoplasm of prostate

Current prostate cancer, which may be relevant to history.

Z80-Z99

Factors influencing health status and contact with health services

Includes personal history of malignant neoplasms (Z85).

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the prostate cancer currently active?

  • Yes

    Is there metastasis?

  • No

    Status post treatment?

Code Comparison

Related Codes Comparison

When to use each related code

Description
History of Prostate Cancer
History of Benign Prostatic Hyperplasia
History of Prostatitis

Documentation Best Practices

Documentation Checklist
  • Prostate carcinoma diagnosis date
  • Primary/secondary/recurrent status
  • Gleason score if applicable
  • TNM staging if applicable
  • Treatment history details

Coding and Audit Risks

Common Risks
  • Unspecified Laterality

    Coding prostate cancer without specifying laterality (right, left, or bilateral) leads to inaccurate reporting and potential claim issues.

  • Active vs. History

    Miscoding active prostate cancer as history of prostate cancer, or vice versa, impacts treatment authorization and quality metrics.

  • Missing Treatment Status

    Failure to document treatment status (e.g., treated, in remission) creates coding ambiguities and affects reimbursement accuracy.

Mitigation Tips

Best Practices
  • Code Z85.46 for personal hx of prostate ca, not C61
  • Ensure clinical documentation supports Z85.46
  • Query physician to clarify active vs. hx of prostate ca
  • Avoid coding C61 with remission status. Use Z85.46
  • Regular CDI audits for accurate prostate ca coding

Clinical Decision Support

Checklist
  • Confirm prostate CA diagnosis: pathology report, imaging, clinical notes.
  • Code Z85.46, personal history of malignant neoplasm of prostate.
  • Document date of initial diagnosis and treatment details.
  • Assess for recurrence: PSA levels, imaging, physical exam.

Reimbursement and Quality Metrics

Impact Summary
  • History of Prostate Carcinoma: Reimbursement and Quality Metrics Impact Summary
  • Keywords: Medical billing, ICD-10 Z85.42, coding accuracy, hospital reporting, prostate cancer, reimbursement, quality metrics, healthcare data
  • Impact 1: Accurate Z85.42 coding maximizes reimbursement for related complications.
  • Impact 2: Proper coding impacts quality reporting on cancer survivorship care.
  • Impact 3: Data integrity influences resource allocation for prostate cancer programs.
  • Impact 4: Precise coding ensures appropriate risk adjustment in value-based care.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes for . Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code Z85.46 for history
  • Document dx date, type
  • Laterality not coded for hx
  • Distinguish from active CA

Documentation Templates

Patient presents with a history of prostate carcinoma.  Initial diagnosis of prostate cancer was established on [Date of original diagnosis] based on [Diagnostic method, e.g., biopsy findings showing adenocarcinoma, Gleason score X].  The patient's original prostate cancer treatment included [Treatment details, e.g., radical prostatectomy, radiation therapy, brachytherapy, androgen deprivation therapy].  Current presentation includes [Reason for visit, e.g., routine follow-up, rising PSA, new onset bone pain].  Physical exam reveals [Relevant findings, e.g., normal rectal exam, palpable lymph nodes].  Prostate-specific antigen (PSA) level is currently [PSA value with units and date].  Imaging studies including [Imaging modality and date, e.g., bone scan, CT scan, MRI] show [Imaging findings, e.g., no evidence of recurrent disease, suspicious lesion in bone].  Assessment: History of prostate cancer, now [Status, e.g., in remission, with biochemical recurrence, metastatic].  Plan includes [Plan of care, e.g., continued surveillance with PSA testing, imaging studies, referral to medical oncology, initiation of hormonal therapy]. Differential diagnoses at initial presentation included benign prostatic hyperplasia (BPH) and prostatitis.  Coding considerations include ICD-10 code Z85.820 (Personal history of malignant neoplasm of prostate) and relevant codes for current symptoms, treatment, and surveillance.  Medical billing should reflect evaluation and management (E M) services as well as any procedures performed.
History of Prostate Carcinoma - AI-Powered ICD-10 Documentation